Dr. Inara McMaster, MD

Claim this profile
Studies Attention Deficit Hyperactivity Disorder (ADHD)
Studies Attention-Deficit/Hyperactivity Disorder (ADHD)
1 reported clinical trial
1 drug studied

Clinical Trials Inara McMaster, MD is currently running

Image of trial facility.

Biofeedback and Breathing Practices

for ADHD

The objective of this research proposal is to examine the combined effects of an integrative approach including biofeedback and breathing practices (Healing Minds) on severity of Attention Deficit Hyperactivity Disorder (ADHD) in youth 6-18 years of age. The investigators hypothesize that ADHD severity will be significantly reduced and Heart Rate Variability (HRV) increased after participation in the 10-week intervention. The investigators also propose that ADHD severity in those patients with prescribed medication but poorly-controlled ADHD will demonstrate the greatest improvement compared to those not prescribed medication and those who have well-controlled ADHD. Our specific aims are as follows: AIM I. Conduct a randomized, placebo-controlled trial (RCT) to examine the effects of a 10-week integrative intervention (Healing Minds) that includes Heart Math Biofeedback and Breathing Practices on ADHD severity and HRV in children and adolescents 6-18 years of age diagnosed with ADHD (N=40). Participants randomized to placebo will be placed on a delayed intervention waiting list and will receive the 10-week Healing Minds intervention afterwards. Hypothesis I: ADHD severity will be significantly reduced and HRV increased following the 10-week Healing Minds Intervention in children and adolescents, 6-18 years of age diagnosed with ADHD compared to a placebo condition AIM Ia. Observe the effects of the Healing Minds intervention in the following sub-groups of youth: ADHD without medication (well versus poorly controlled) ADHD with medication (well versus poorly controlled) Hypothesis Ia: Participants without medication will experience a significantly greater reduction in ADHD severity compared to those with medication. Poorly controlled participants with medication will experience the greatest reduction in ADHD severity. AIM Ib. Explore the effects of the intervention on related mental health conditions: PTSD Anxiety Resilience
Recruiting1 award N/A2 criteria

More about Inara McMaster, MD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Inara McMaster, MD has experience with
  • Healing Minds
Breakdown of trials Inara McMaster, MD has run
Attention Deficit Hyperactivity Disorder (ADHD)
Attention-Deficit/Hyperactivity Disorder (ADHD)

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Inara McMaster, MD specialize in?
Inara McMaster, MD focuses on Attention Deficit Hyperactivity Disorder (ADHD) and Attention-Deficit/Hyperactivity Disorder (ADHD). In particular, much of their work with Attention Deficit Hyperactivity Disorder (ADHD) has involved treating patients, or patients who are undergoing treatment.
Is Inara McMaster, MD currently recruiting for clinical trials?
Yes, Inara McMaster, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Inara McMaster, MD has studied deeply?
Yes, Inara McMaster, MD has studied treatments such as Healing Minds.
What is the best way to schedule an appointment with Inara McMaster, MD?
Apply for one of the trials that Inara McMaster, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.